M. Gillison

Journal of Clinical Oncology · 2000–2020

A researcher in the Science corpus: 14 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom M. Gillison trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Anil K. Chaturvedi

Who trusts M. Gillison overall

1. Anil K. Chaturvedi
2. S. Marur
3. C. R. Leemans
4. Edgar P. Simard

Papers from M. Gillison's perspective

Ordered by how strongly the researchers M. Gillison trusts endorse each paper. Same corpus, a different order for every researcher.

1. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. (Journal of the National Cancer Institute)
2. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. (Journal of the National Cancer Institute)
3. Improved Amplification of Genital Human Papillomaviruses (Journal of Clinical Microbiology)
4. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
5. Nonparametric Estimation from Incomplete Observations
6. Prevalence of HPV infection among females in the United States. (Journal of the American Medical Association (JAMA))
7. Prevalence of Oral HPV Infection in the United States, 2009–2010 (Journal of the American Medical Association (JAMA))
8. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. (Journal of the National Cancer Institute. Monographs)
9. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. (Journal of the National Cancer Institute)
10. Effects of tobacco smoke on immunity, inflammation and autoimmunity. (Journal of Autoimmunity)

Their papers

• Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. (2020) — 994 citations
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) (2019) — 606 citations
• Radiotherapy plus cetuximab or cisplatin for human papillomavirus (HPV)-positive oropharyngeal cancer: a randomized, multicenter, non-inferiority clinical trial (2018) — 1,051 citations
• Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. (2015) — 1,011 citations
• Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. (2014) — 731 citations
• J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States (2014) — 2,560 citations
• Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. (2013) — 1,242 citations
• Prevalence of Oral HPV Infection in the United States, 2009–2010 (2012) — 1,029 citations
• Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection (2009) — 608 citations
• Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. (2008) — 1,568 citations
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. (2008) — 2,711 citations
• Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. (2008) — 1,562 citations
• Case-control study of human papillomavirus and oropharyngeal cancer. (2007) — 2,650 citations
• Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. (2000) — 3,171 citations